Director, AI Sciences

Company Summary:

Quotient Therapeutics develops breakthrough medicines informed by natural somatic genetic diversity present in patients. Through our work in somatic genomics, we are forging a new status quo for biopharma research and development across a broad pipeline of internal and partnered programs.  We are a privately held, early-stage company and are an equal opportunity employer.

Quotient was founded by